161 related articles for article (PubMed ID: 11057932)
1. Antiretroviral therapy for drug users.
Clarke SM; Mulcahy FM
Int J STD AIDS; 2000 Oct; 11(10):627-31. PubMed ID: 11057932
[TBL] [Abstract][Full Text] [Related]
2. What's new for injection drug users with HIV infection?
Clarke SM; Mulcahy FM
Sex Transm Infect; 2003 Apr; 79(2):80-3. PubMed ID: 12690121
[No Abstract] [Full Text] [Related]
3. Cost-effectiveness of integrating methadone maintenance and antiretroviral treatment for HIV-positive drug users in Vietnam's injection-driven HIV epidemics.
Tran BX; Ohinmaa A; Duong AT; Nguyen LT; Vu PX; Mills S; Houston S; Jacobs P
Drug Alcohol Depend; 2012 Oct; 125(3):260-6. PubMed ID: 22436971
[TBL] [Abstract][Full Text] [Related]
4. Methadone dosing strategies in HIV-infected injection drug users enrolled in a directly observed therapy program.
Tossonian HK; Raffa JD; Grebely J; Trotter B; Viljoen M; Mead A; Khara M; McLean M; Duncan F; Fraser C; DeVlaming S; Conway B
J Acquir Immune Defic Syndr; 2007 Jul; 45(3):324-7. PubMed ID: 17468668
[TBL] [Abstract][Full Text] [Related]
5. Treatment of opioid dependence and coinfection with HIV and hepatitis C virus in opioid-dependent patients: the importance of drug interactions between opioids and antiretroviral agents.
McCance-Katz EF
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S89-95. PubMed ID: 16265622
[TBL] [Abstract][Full Text] [Related]
6. Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users.
Uhlmann S; Milloy MJ; Kerr T; Zhang R; Guillemi S; Marsh D; Hogg RS; Montaner JS; Wood E
Addiction; 2010 May; 105(5):907-13. PubMed ID: 20331553
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
[TBL] [Abstract][Full Text] [Related]
8. Directly observed antiretroviral therapy for injection drug users with HIV infection.
Clarke S; Keenan E; Ryan M; Barry M; Mulcahy F
AIDS Read; 2002 Jul; 12(7):305-7, 312-6. PubMed ID: 12161852
[TBL] [Abstract][Full Text] [Related]
9. Ageing with HIV: medication use and risk for potential drug-drug interactions.
Marzolini C; Back D; Weber R; Furrer H; Cavassini M; Calmy A; Vernazza P; Bernasconi E; Khoo S; Battegay M; Elzi L;
J Antimicrob Chemother; 2011 Sep; 66(9):2107-11. PubMed ID: 21680580
[TBL] [Abstract][Full Text] [Related]
10. Impact of accessing methadone on the time to initiating HIV treatment among antiretroviral-naive HIV-infected injection drug users.
Wood E; Hogg RS; Kerr T; Palepu A; Zhang R; Montaner JS
AIDS; 2005 May; 19(8):837-9. PubMed ID: 15867502
[TBL] [Abstract][Full Text] [Related]
11. Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward.
Wolfe D; Carrieri MP; Shepard D
Lancet; 2010 Jul; 376(9738):355-66. PubMed ID: 20650513
[TBL] [Abstract][Full Text] [Related]
12. Access to antiretroviral therapy in HIV-infected injection drug users.
Antela A
AIDS; 2001 Sep; 15(13):1727-8. PubMed ID: 11546949
[No Abstract] [Full Text] [Related]
13. Viral suppression among HIV-infected methadone-maintained patients: The role of ongoing injection drug use and adherence to antiretroviral therapy (ART).
Shrestha R; Copenhaver MM
Addict Behav; 2018 Oct; 85():88-93. PubMed ID: 29879611
[TBL] [Abstract][Full Text] [Related]
14. Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone.
Altice FL; Friedland GH; Cooney EL
AIDS; 1999 May; 13(8):957-62. PubMed ID: 10371177
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of methadone maintenance treatment for HIV-positive drug users in Vietnam.
Tran BX; Ohinmaa A; Duong AT; Do NT; Nguyen LT; Mills S; Houston S; Jacobs P
AIDS Care; 2012; 24(3):283-90. PubMed ID: 21936718
[TBL] [Abstract][Full Text] [Related]
16. Assessing limiting factors to the acceptance of antiretroviral therapy in a large cohort of injecting drug users.
Clarke S; Delamere S; McCullough L; Hopkins S; Bergin C; Mulcahy F
HIV Med; 2003 Jan; 4(1):33-7. PubMed ID: 12534957
[TBL] [Abstract][Full Text] [Related]
17. Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users.
Wood E; Kerr T; Zhang R; Guillemi S; Palepu A; Hogg RS; Montaner JS
HIV Med; 2008 Aug; 9(7):503-7. PubMed ID: 18484977
[TBL] [Abstract][Full Text] [Related]
18. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
[TBL] [Abstract][Full Text] [Related]
19. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).
Spire B; Lucas GM; Carrieri MP
Int J Drug Policy; 2007 Aug; 18(4):262-70. PubMed ID: 17689374
[TBL] [Abstract][Full Text] [Related]
20. Use of antiretroviral therapies by HIV-infected persons receiving methadone maintenance.
Stein MD; Urdaneta ME; Clarke J; Maksad J; Sobota M; Hanna L; Markson LE
J Addict Dis; 2000; 19(1):85-94. PubMed ID: 10772605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
